All stock lists
Lycia Therapeutics, Inc. (NASDAQ:LYCA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
27.73+2.68 (+10.70%)
Insider Score
––Not scored
LYCA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
LYCA Stock Insider Trading Activity
LYCA stock’s insider trading shows 6 purchases for an estimated $37.65M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$37.65M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 8,729 | $25.84 | $225.56K | 0.1% | 6,794,166 | Oct 27, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 31,067 | $26.84 | $833.84K | 0.5% | 6,825,233 | Oct 27, 2026 | — | Form 4 |
| Versant Ventures VII GP, L.P. Other | Converted | 5,631,425 | — | — | New | 5,631,425 | Oct 26, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 1,944,444 | $18.00 | $35.00M | 40.2% | 6,777,176 | Oct 26, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 8,261 | $26.97 | $222.80K | 0.1% | 6,785,437 | Oct 26, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Converted | 4,779,793 | — | — | 9029% | 4,832,732 | Oct 26, 2026 | — | Form 4 |
| Versant Ventures VII GP, L.P. Other | Converted | 1,393,882 | — | — | New | 1,393,882 | Oct 26, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 28,379 | $26.11 | $740.98K | 116% | 52,939 | Oct 23, 2026 | — | Form 4 |
| Venrock Healthcare Capital Partners III, L.P. Other | Buy | 24,560 | $25.68 | $630.70K | New | 24,560 | Oct 23, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.